In vivo patterns of apoptosis-regulating protein expression in Kaposi's sarcoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 5, Issue 2, 1997, Pages 104-110

  Montmayeur, Fabienne ^a   Krajewski, Stanislaw ^c   Bejui Thivolet, Françoise ^b   Schlaifer, Daniel ^a   Delsol, Georges ^a   Reed, John C ^c   Brousset, Pierre ^a  

^a CHU PURPAN   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c BURNHAM INSTITUTE   (United States)

Author keywords

AIDS; Apoptosis; Immunohistochemistry; Kaposi's sarcoma

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; PRIORITY JOURNAL;

EID: 0031011309     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199706000-00005     Document Type: Article

References (40)

1. Roth WK, Brandstetter H, Stürzl M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 1992; 6:895-913.
2. Herndier BG, Werner A, Arnstain P, et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogentic tumours in animal. AIDS 1994;8:575-81.
3. Ensoli Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein induction of Kaposi's sarcoma. Nature 1994;371:674-80.
4. Ensoli B, Markham P, Kao V, et al. Block of AIDS Kaposi's sarcoma cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. J Clin Invest 1994;94:1736-46.
5. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B. Cytokines from activated T-cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995; 95:1723-34.
6. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-8.
7. Archibald CP, Schechter MT, Le TN, Craib KJP, Montaner JSG, O'Shaughnessy MV. Evidence for a sexual transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiology 1992;3:203-9.
8. Fiedman-Kien AE, Saltzman BR, Cao YZ, et al. Kaposi's sarcoma in HIV-negative homosexual men. Lancet 1990; 335:168-9.
9. Moore PS, Yuan Chang. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995;332:1181-5.
10. Rady PL, Yen A, Rollefson JL, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995;345:1339-40.
11. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
12. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993;74:777-9.
13. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
14. Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-5.
15. Le Brun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993;142:743-53.
16. Lu QL, Poulsom R, Wong L, Hanby AM. BCL-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 1993;169:431-7.
17. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. Immunohistochemical analysis of Mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994;145:515-25.
18. Vogelstein B, Kinzler W. p53 function and dysfunction. Cell 1992;70:523-6.
19. Myashita T, Krajewski S, Krajewska M, et al. Tumor suppressor gene p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-805.
20. Krajewski S, Blomqvist C, Franssila K, et al. Reduced expression of proapoptotic gene BAX is associated with poor response to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 1995;55:4471-8.
21. Krajewski S, Krajewska M, Shabaik A, et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 1994;54:5501-7.
22. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
23. Boise LH, Gonzalez-Garcia M, Postema CE, et al. Bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
24. Kozopas KM, YangT, Buchan HL, Zhou P, Craig RW. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993;90:3516-20.
25. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bc12. Am J Pathol 1994;145:1323-36.
26. Krajewski S, Bodrug S, Krajewska M, et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Am J Pathol 1995;146:1309-19.
27. Pezzela F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990; 137:225-32.
28. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994;79:189-92.
29. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-8.
30. Schlaifer D, March M, Krajewski S, et al. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood 1995;85:2671-4.
31. Hanada M, Aimé-Sempé C, Sato T, Reed JC. Structure-function analysis of bcl-2 protein: identification of conserved domains important for homodimerization with bcl-2 and heterodimerization with bax. J Biol Chem 1995;270:11262-9.
32. Sato T, Hanada M, Bodrug S, et al. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 1994;91:9238-42.
33. Dada MA, Chetty R, Biddolph SC, Schneider JW, Gatter KC. The immunoexpression of Bcl-2 and p53 in Kaposi's sarcoma. Histopathology 1996;29:159-63.
34. Morris CB, Gendelman R, Marrogi AJ, et al. Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am J Pathol 1996;148:1055-63.
35. Foreman KE, Wrone-Smith T, Boise LH, et al. Kaposi's sarcoma tumor cells preferentially express Bcl-XL. Am J Pathol 1996;149:795-803.
36. Mateo MS, Sanchez-Beato M, Martinez JC, Orfao A, Orradre JL, Piris MA. p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemaglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections. J Clin Pathol 1995;48:151-9.
37. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC. Cloning and functional analysis of BAG-1: a novel bcl-2 binding protein with anti-cell death activity. Cell 1995;80:279-84.
38. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, heterodimeric partner for bcl-x-L, and bcl-2, displaces bax and promotes cell death. Cell 1995;80:285-91.
39. Boyd JM, Malstrom S, Subramanian T, et al. Adenovirus E1B 19kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994;79:341-51.
40. Lunardi-Iskandar Y, Bryant JL, Zenan RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995;375:64-8.